Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Biophama VC, deal values and exits all rise in Q3: Pitchbook
Biopharma brought in $7.2 billion across 187 deals in 2024's third quarter, jumping from $5.8 billion in the second quarter.
Gabrielle Masson
Nov 20, 2024 6:15am
Septerna goes public with upsized offering of $288M
Oct 25, 2024 10:29am
Septerna plans $158M IPO to fund readouts for GPCR pipeline
Oct 21, 2024 8:30am
Upstream swells IPO to $255M as it lists alongside CAMP4
Oct 11, 2024 5:18am
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
Oct 7, 2024 8:44am
Pentixapharm scores $22M in IPO to advance radiopharma trials
Oct 3, 2024 10:36am
